Physician profile
Daniel J Monzon
NPI 1073984837
$1,433.01
in general payments reported to CMS, 2019-2025
8 companies · $735 in 2025
The $735 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $13.87 · 2022: $55.73 · 2023: $42.47 · 2024: $462 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $500.28 | 2022-2025 | Acuvue |
| Dompe US, INC. | $261.52 | 2024-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $243.74 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $129.60 | 2024 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $123.71 | 2019 | |
| Lkc Technologies, INC. | $85.77 | 2025 | |
| Coopervision INC. | $74.52 | 2024-2025 | Myday Contact Lens |
| Abb Con-Cise Optical Group LLC | $13.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Monzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.